| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/01/2006 | WO2006057462A1 Peptide migrating into chromoplast in petal and method of constructing plant having yellowish petal by using the peptide |
| 06/01/2006 | WO2006057454A1 A method of prime-boost vaccination |
| 06/01/2006 | WO2006057450A1 L-amino acid-producing bacterium and a method for producing l-amino acid |
| 06/01/2006 | WO2006057391A1 Method of detecting interaction between proteins |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057341A1 Industrially useful microorganism |
| 06/01/2006 | WO2006057339A1 Method of producing antibody |
| 06/01/2006 | WO2006057306A1 Poaceous plant with enhanced stress tolerance and/or productivity and method of creating the same |
| 06/01/2006 | WO2006057289A1 Novel shuttle vector |
| 06/01/2006 | WO2006057217A1 Dfrp proteins regulating drg proteins and utilization of the same |
| 06/01/2006 | WO2006056825A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 06/01/2006 | WO2006056823A1 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 06/01/2006 | WO2006056821A1 Heterologus expression of trypanothione reductase from leishmania donovani in a prokaryotic system |
| 06/01/2006 | WO2006056753A2 Humanised baculovirus |
| 06/01/2006 | WO2006056733A1 Gamma-delta t cell receptors |
| 06/01/2006 | WO2006056701A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | WO2006056623A1 Ccr6-deficient mice or cells and modulation of inflammatory diseases |
| 06/01/2006 | WO2006056617A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 06/01/2006 | WO2006056615A1 Enhancer-containing gene trap vectors for random and targeted gene trapping |
| 06/01/2006 | WO2006056597A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | WO2006056484A1 Protein isolation and purification |
| 06/01/2006 | WO2006056483A1 Production of proteins |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |
| 06/01/2006 | WO2006056468A1 Increase in yield by reducing gene expression |
| 06/01/2006 | WO2006056370A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 06/01/2006 | WO2006056340A2 Method for determining genotoxicity |
| 06/01/2006 | WO2006056306A2 Hydrogel polymeric conjugates of a prodrug |
| 06/01/2006 | WO2006056259A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | WO2006056245A1 Use of a human chitinase-like protein in diagnosis and therapy |
| 06/01/2006 | WO2006056176A2 Storage-induced promoter |
| 06/01/2006 | WO2006056142A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 06/01/2006 | WO2006056103A1 An expression vector encoding coronavirus-like particles |
| 06/01/2006 | WO2006056050A1 Production of heterologous proteins in caulobacter |
| 06/01/2006 | WO2006035432A3 Gene silencing for use in dermatology |
| 06/01/2006 | WO2006032041A3 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 06/01/2006 | WO2006031780A3 Promoter molecules for use in plants |
| 06/01/2006 | WO2006031467A9 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/01/2006 | WO2006029538A8 Sialyltransferases comprising conserved sequence motifs |
| 06/01/2006 | WO2006029485A3 Overexpressed and purified aspergillus ficuum oxidase and nucleic acid encoding the same |
| 06/01/2006 | WO2006029296A3 Inositol polyphosphate 2-kinase genes and uses thereof |
| 06/01/2006 | WO2006026447A9 Production of tnfr-Ig fusion protein |
| 06/01/2006 | WO2006026238A3 Rna interference in avians |
| 06/01/2006 | WO2006024547A3 Protease resistant human and non-human hmgb1 box-a mutants and their therapeutic/diagnostic use |
| 06/01/2006 | WO2006019430A3 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 06/01/2006 | WO2006015789A3 Method for modulating gene expression by modifying the cpg content |
| 06/01/2006 | WO2006014752A3 Use of apoptosis-specific eif-5a sirnas and antisense polynucleotides to inhibit/suppress an inflammatory response |
| 06/01/2006 | WO2006013103A3 Inducible gene expression |
| 06/01/2006 | WO2006010106A3 Dna-based vaccination of retroviral-infected individuals undergoing treatment |
| 06/01/2006 | WO2006008468A3 Adenovirus vector and method to manipulate the adenovirus genome |
| 06/01/2006 | WO2006006956A3 Altering root structure during plant development |
| 06/01/2006 | WO2005123766A3 Methods of making nanotechnological and macromolecular biomimetic structures |
| 06/01/2006 | WO2005121331A9 Truncated galnact2 polypeptides and nucleic acids |
| 06/01/2006 | WO2005117975A3 Methods for treating vascular disease |
| 06/01/2006 | WO2005112968A3 Method of using recombinant human antithrombin for neurocognitive disorders |
| 06/01/2006 | WO2005111216A3 Methods for modifying plant characteristics |
| 06/01/2006 | WO2005109995A3 Thermostable gluconate dehydratase and use thereof |
| 06/01/2006 | WO2005103692A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 06/01/2006 | WO2005100395A3 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE |
| 06/01/2006 | WO2005095607A3 ANTI-SENSE OLIGONUCLEOTIDES DIRECTED TOWARDS THE HIV ψ DOMAIN |
| 06/01/2006 | WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 06/01/2006 | WO2005090599A3 Methods and adaptors for analyzing specific nucleic acid populations |
| 06/01/2006 | WO2005076786A3 Colon carcinoma related oligonucleotides and methods of use |
| 06/01/2006 | WO2005059121A3 Dominant gene suppression transgenes and methods of using same |
| 06/01/2006 | WO2005041757A3 Detection of neuropeptides associated with pelvic pain disorders and uses thereof |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2005017123A3 Mptens as modifiers of the pten pathway and methods of use |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117416 Isolated polynucleotide which encodes a transmembrane protein with similarities to plasma membrane Na+/H+ antiporters from bacteria and fungi confering salt tolerance |
| 06/01/2006 | US20060117415 Expression cassettes for root-preferential expression in plants |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060117413 generating transgenic plantS comprising introducing into a somatic embryo, a polynucleotide encoding dihydrodipicolinate synthase (DHPS) polypeptide, effective to render the embryo resistant to S-2-aminoethylcysteine; herbicide resistance |
| 06/01/2006 | US20060117412 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents |
| 06/01/2006 | US20060117411 Enhancing plant pathogen resistance via increasing BiP levels |
| 06/01/2006 | US20060117410 Locked nucleic acid containing heteropolymers and related methods |
| 06/01/2006 | US20060117409 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes |
| 06/01/2006 | US20060117408 Expression cassettes for guard cell-preferential expression in plants |
| 06/01/2006 | US20060117407 Method of producing transgenic maize using direct transformation of commercially important genotypes |
| 06/01/2006 | US20060117406 Soybean cultivar 917013 |
| 06/01/2006 | US20060117405 Soybean cultivar 900213 |
| 06/01/2006 | US20060117404 Soybean cultivar 1000126 |
| 06/01/2006 | US20060117403 Soybean cultivar 901023 |
| 06/01/2006 | US20060117402 Controlling gene expression; genetic engineered dna; transforming plant |
| 06/01/2006 | US20060117401 Method for producing aminoacids |
| 06/01/2006 | US20060117400 Introducing into plant plastids first and second DNA molecules containing a regions homologous to regions of the plastome for directing plastome integration and sequences of interest; selecting transformants having an integration sequence stably integrated in the plastome |
| 06/01/2006 | US20060117398 Suppression of endogenous immunoglobulin expression |
| 06/01/2006 | US20060117395 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 06/01/2006 | US20060117394 Chimeric cells coding heterologous immunoglobulin for treatment, prevention and diagnosis of infections and cell proliferative disorders |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060116505 Glucose and/or fructose transporter naglt1 and its gene |
| 06/01/2006 | US20060116348 Using the hyaluronate synthase from Pasteurella multocida; coatings for biomaterials wherein the coatings provide protective properties to the biomaterial and/or act as a bioadhesive; coatings could be applied to electrical devices, sensors, catheters |
| 06/01/2006 | US20060116344 Remedy and preventive for diseases caused by NF-kB |
| 06/01/2006 | US20060116341 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 06/01/2006 | US20060116339 Antisense modulation of purinoreceptor p2x3 |
| 06/01/2006 | US20060116323 Tumor-inhibiting protein and the use thereof |
| 06/01/2006 | US20060116317 Dyeing keratin material; using ninhydrin material |
| 06/01/2006 | US20060116315 Method of screening agent for improving memory and learning ability |
| 06/01/2006 | US20060115895 Fish disease models and uses thereof |
| 06/01/2006 | US20060115886 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma, aspergillus |
| 06/01/2006 | US20060115885 Technique of removing marker gene by transient expression of site-specific recombinase gene |
| 06/01/2006 | US20060115881 High eicosapentaenoic acid producing strains of Yarrowia lipolytica |